PreMarket Price
Molina Healthcare, Inc. (MOH) logo

Molina Healthcare, Inc. (MOH)

Market Closed

Sector: Financial Services · Industry: Hospital & Medical Service Plans

AnalystsHold25 analysts
EW Score 35/65 · #218Mkt Cap 10.09BP/E 53.3ROE 4.6%52wk $122.65–$242.88
Profilev50g45p16h63q72

Price History

5-Year Weekly Candlestick Chart

Profile

Valuation — 50/100 (Moderate) P/E vs own history: 94th pct → 0/25 FCF yield: 2.5% → 5/25 P/S: 0.2x → 25/25 EV/EBIT: 10.7x → 20/25Valuation50Growth — 45/100 (Weak) Revenue CAGR: 13.1% → 20/25 Net income CAGR: -8.0% → 0/25 EPS CAGR 5Y: -5.6% → 0/25 Fwd implied growth: 44.5% → 25/25Growth45Profitability — 16/100 (Weak) ROIC: n/a → 0/25 ROE: 4.6% → 5/25 Net margin: 0.4% → 6/25 Operating margin: 1.0% → 5/25Profitability16Financial Health — 63/100 (Moderate) Altman Z: 1.85 → 10/25 Current ratio: 1.63 → 18/25 Interest coverage: 4.1x → 10/25 Net cash / debt: Net cash → 25/25Health63Quality — 72/100 (Moderate) Piotroski F: 4/9 → 10/25 Beneish M: -2.16 → 12/25 FCF conversion: 134% → 25/25 Margin stability: σ 2.4% → 25/25Quality72

profitability and growth lag behind.

How is each axis scored?
  • Valuation50/100 · Moderate
    • P/E vs own history (94th pct)0/25
    • FCF yield (2.5%)5/25
    • P/S (0.2x)25/25
    • EV/EBIT (10.7x)20/25
  • Growth45/100 · Weak
    • Revenue CAGR (13.1%)20/25
    • Net income CAGR (-8.0%)0/25
    • EPS CAGR 5Y (-5.6%)0/25
    • Fwd implied growth (44.5%)25/25
  • Profitability16/100 · Weak
    • ROIC (n/a)0/25
    • ROE (4.6%)5/25
    • Net margin (0.4%)6/25
    • Operating margin (1.0%)5/25
  • Financial Health63/100 · Moderate
    • Altman Z (1.85)10/25
    • Current ratio (1.63)18/25
    • Interest coverage (4.1x)10/25
    • Net cash / debt (Net cash)25/25
  • Quality72/100 · Moderate
    • Piotroski F (4/9)10/25
    • Beneish M (-2.16)12/25
    • FCF conversion (134%)25/25
    • Margin stability (σ 2.4%)25/25

About Molina Healthcare, Inc.

Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. Show more

The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.

Headquarters: LONG BEACH, CA · Employees: 19,000 · Website ↗

Insider Transactions

Recent SEC Form 4 filings

  • Sell
    Tax withholding · filed 2026-07-02
    -183 sh
    2026-07-01
  • Buy
    Grant / award · filed 2026-07-02
    +237 sh
    2026-07-01
  • Buy
    Grant / award · filed 2026-07-02
    +237 sh
    2026-07-01
  • Buy
    Grant / award · filed 2026-07-02
    +237 sh
    2026-07-01
  • Buy
    Grant / award · filed 2026-07-02
    +237 sh
    2026-07-01

+3 more recent filings

Key Metrics

Financial snapshot — pillar inputs plus per-share and market context

Valuation

50C
P/E (TTM)53.3xD

Grade D: ExpensivePrice / TTM EPS (own statements) — vs own 5Y history: 7.3x–67.0x · 94th pct

P/FCF9.4xA

Grade A: CheapPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative

FCF Yield2.5%C

Grade C: LowTTM FCF / Market Cap — vs own 5Y history: -8.8%–17.5% · 31st pct

P/S (TTM)0.22xA

Grade A: CheapPrice / TTM Revenue (own statements) — vs own 5Y history: 0.1x–0.8x · 15th pct

EV/EBIT10.7xA

Grade A: CheapEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 1.5x–16.5x · 69th pct

EV/Sales0.2xA

Grade A: CheapEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple

Forward P/E36.9xD

Grade D: ExpensivePrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth

P/B Ratio2.47xA

Grade A: FairPrice to Book Value. Neg. equity = heavy buybacks

PEG Ratio—

Finnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)

Dividend Yield—

TTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress

Payout Ratio—

Dividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable

P/E vs own 5Y historyAbove average · 94th pct

Profitability

16E
ROIC—

NOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat

ROE4.6%D

Grade D: WeakReturn on Equity. Neg. equity = heavy buybacks

ROA-0.0%D

Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit

Net Margin0.4%D

Grade D: LowNet Income / Revenue

Operating Margin1.0%D

Grade D: LowTTM EBIT / TTM Revenue

Gross Margin12.9%D

Grade D: LowGross Profit / Revenue

FCF Margin0.6%D

Grade D: LowFCF / Revenue

True FCF Margin0.4%D

Grade D: LowTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost

Financial Health

63B
Altman Z-Score1.85C

Grade C: Gray zoneBankruptcy risk. >3 Safe, <1.8 Distress

Current Ratio1.63xC

Grade C: OkCurrent Assets/Liabilities

Quick Ratio1.61xA

Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory

Interest Coverage4.1xC

Grade C: OkEBIT/Interest. >10 Strong

Debt RepaymentNet CashA

Grade A: FastYears to repay net debt via FCF

Net Debt/EBITNet CashA

Grade A: LowLeverage. <2x Low, >4x High

Debt/Equity0.92xA

Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.

Cash / Debt2.46xA

Grade A: CoveredCash covers how much of total debt. >1 = could repay all debt from cash

Growth

45D+
Revenue CAGR13.1%C

Grade C: OkCompound annual revenue growth (up to 5Y depending on data availability)

Net Income CAGR-8.0%D

Grade D: LowCompound annual net income growth (up to 5Y depending on data availability)

EPS CAGR (5Y)-5.6%D

Grade D: LowCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0

Implied EPS Growth44.5%A

Grade A: HighImplied 1Y EPS growth from forward P/E vs our TTM EPS. Sparse — only where forward estimates exist

Dilution (5Y)-11.5%A

Grade A: BuybacksShare count change over 5Y

SBC / Net Income28.2%D

Grade D: HighStock-based comp/Net income. >30% = dilution risk

SBC / Revenue0.1%A

Grade A: LowTTM stock-based comp / TTM Revenue

Quality

1/10 Loss Years72B+
Piotroski F-Score4/9C

Grade C: AverageFinancial strength 0–9. >7 Strong

Beneish M-Score-2.16C

Grade C: Gray zoneEarnings manipulation risk. < -2.22 Safe

FCF Conversion133.5%A

Grade A: StrongFCF / Net Income

Margin Stability2.4%A

Grade A: StableEBIT margin std deviation. Lower = stable

Capex / Revenue0.2%A

Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business

Asset Turnover2.92xA

Grade A: HighRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales

More metrics — Per Share, Balance Sheet, Market

Per Share

EPS (TTM)$3.63

Own TTM net income / shares — same earnings basis as P/E

Cash / Share$161.88

Cash & short-term investments per share (Finnhub)

Book Value / Share$79.78

Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks

Balance Sheet

Total Debt$3.77B

Total debt obligations (short + long term)

Cash & Equiv.$9.25B

Cash and short-term investments

Net Debt$-5.48BA

Grade A: Net CashTotal Debt minus Cash. Negative = Net Cash position

Total Equity$4.08B

Shareholders' equity (book value)

Asset / Liability1.33xC

Grade C: AdequateTotal Assets / Total Liabilities

Market

Market Cap$10.09B

Current Market Capitalization

Beta0.74B

Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings

Takeaway

Company is effectively debt-free after netting cash. · Current P/E of 53.3x sits at the 94th percentile of its historical range.

How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.

Financials as of Mar 2026 · Ratio snapshot Sep 25, 2026

Key Insights: Molina Healthcare, Inc. (MOH)

Piotroski F-Score of 4/9 indicates mixed fundamentals for Molina Healthcare, Inc.. Altman Z-Score of 1.85 falls in the grey zone (1.81–2.99) — financial distress is unlikely but not ruled out.

  • Company is effectively debt-free after netting cash.
  • Molina Healthcare, Inc. posted a net loss in 1 of 10 available completed fiscal years (2016–2025).

See how MOH ranks on the Capex Tracker — top 50 capital spenders compared.

No significant market moves for MOH in the last 30 days.

See MOH move history →

Frequently Asked Questions about MOH

Is MOH stock a buy right now?

PreMarketPrice's quantitative model rates Molina Healthcare, Inc.'s financial health at 63/100. This is a data-driven snapshot of fundamentals, not investment advice.

Is MOH stock overvalued?

Molina Healthcare, Inc. trades at a trailing P/E of 53.3 and our valuation score rates it 50/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.

When does Molina Healthcare, Inc. report earnings?

No confirmed earnings date is currently scheduled for MOH. The Earnings section lists recent reports and updates as dates are announced.

What sector does Molina Healthcare, Inc. operate in?

Molina Healthcare, Inc. operates in the Financial Services sector, within the Hospital & Medical Service Plans industry. The Related Stocks section lists sector peers for comparison.

What does Molina Healthcare, Inc. do?

Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare.

About Molina Healthcare, Inc. (MOH) Stock

Molina Healthcare, Inc. (MOH) is a US-listed stock operating in the Financial Services sector, specifically the Hospital & Medical Service Plans industry. Real-time pricing data for Molina Healthcare, Inc. is available on this page with a market capitalization of $10.1 billion. The financial health score for MOH is 63/100, which indicates good financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for MOH stock.

MOH Stock Analysis & Key Metrics

On PreMarketPrice, you can track Molina Healthcare, Inc. (MOH) across multiple dimensions:

Is MOH a Good Stock to Buy?

This page provides data-driven analysis to help you evaluate Molina Healthcare, Inc. (MOH) as an investment. The financial health score of 63/100 suggests good financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.

Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Molina Healthcare, Inc. (MOH) trades on NYSE. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.